Pediatrix Medical Group, Inc. (MD)
NYSE:MD
Want to see MD full AI Analyst Report?
MD Stock Chart & Stats
$23.07
$0.16(1.27%)
At close: 4:00 PM EST
$23.07
$0.16(1.27%)
Day’s Range― - ―
52-Week Range$11.84 - $24.99
Previous CloseN/A
Volume66.51K
Average Volume (3M)852.63K
Market Cap
$2.00B
Enterprise Value$2.36B
Total Cash (Recent Filing)$328.97M
Total Debt (Recent Filing)$629.72M
Price to Earnings (P/E)11.5
Beta0.60
Next Earnings
Jul 30, 2026EPS Estimate
0.59Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)2.06
Shares Outstanding82,121,910
10 Day Avg. Volume654,196
30 Day Avg. Volume852,634
Financial Highlights & Ratios
PEG Ratio-0.04
Price to Book (P/B)2.11
Price to Sales (P/S)0.95
P/FCF Ratio7.22
Enterprise Value/Market Cap1.18
Enterprise Value/Revenue1.22
Enterprise Value/Gross Profit4.73
Enterprise Value/Ebitda8.45
Forecast
1Y Price Target
$24.20Price Target Upside4.90% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering5
EPS Forecast (FY)2.28
Revenue Forecast (FY)$1.94B
Bulls Say, Bears Say
Bulls Say
Capital AllocationStrong cash flow generation and low leverage enable continued share repurchase activity, which can support shareholder value and reduce share count over time.
Operational FocusCompleted exits from noncore operations like primary and urgent care sites concentrate resources on higher-margin hospital services, improving profitability and earnings quality.
Revenue QualityAnalyst highlights improved reimbursement rates and a favorable payer mix that could sustain same-unit revenue growth and help stabilize top-line performance despite softer patient volumes.
Bears Say
Demand HeadwindsDeclines in patient volumes, including fewer neonatal intensive care days, combined with low fertility rates are reducing revenue opportunities for pediatric and neonatal services.
Profitability And MarginsAn adjusted EBITDA shortfall and weaker-than-expected margins indicate pressure on profitability that could prompt downward revisions to earnings expectations.
Rising Operating ExpensesHigher operating costs, driven by payroll and general administrative expenses, are compressing operating margins and limiting near-term profit expansion.
Pediatrix Medical Group News
MD FAQ
What was Pediatrix Medical Group, Inc.’s price range in the past 12 months?
Pediatrix Medical Group, Inc. lowest stock price was $11.84 and its highest was $24.99 in the past 12 months.
What is Pediatrix Medical Group, Inc.’s market cap?
Pediatrix Medical Group, Inc.’s market cap is $2.00B.
When is Pediatrix Medical Group, Inc.’s upcoming earnings report date?
Pediatrix Medical Group, Inc.’s upcoming earnings report date is Jul 30, 2026 which is in 42 days.
How were Pediatrix Medical Group, Inc.’s earnings last quarter?
Pediatrix Medical Group, Inc. released its earnings results on May 05, 2026. The company reported $0.44 earnings per share for the quarter, beating the consensus estimate of $0.38 by $0.06.
Is Pediatrix Medical Group, Inc. overvalued?
According to Wall Street analysts Pediatrix Medical Group, Inc.’s price is currently Undervalued.
Does Pediatrix Medical Group, Inc. pay dividends?
Pediatrix Medical Group, Inc. does not currently pay dividends.
What is Pediatrix Medical Group, Inc.’s EPS estimate?
Pediatrix Medical Group, Inc.’s EPS estimate is 0.59.
How many shares outstanding does Pediatrix Medical Group, Inc. have?
Pediatrix Medical Group, Inc. has 82,121,910 shares outstanding.
What happened to Pediatrix Medical Group, Inc.’s price movement after its last earnings report?
Pediatrix Medical Group, Inc. reported an EPS of $0.44 in its last earnings report, beating expectations of $0.38. Following the earnings report the stock price went down -7.05%.
Which hedge fund is a major shareholder of Pediatrix Medical Group, Inc.?
Currently, no hedge funds are holding shares in MD
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Pediatrix Medical Group Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$24.20 (4.90% Upside)
$24.20 (4.90% Upside)
Blogger Sentiment
Bullish
MD Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 507.3K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $855.7K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Negative
Last 7 Days ▼ 1.1%
Last 30 Days ▼ 0.3%
Last 30 Days ▼ 0.3%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
74.74%
12-Months-Change
Fundamentals
Return on Equity
20.09%
Trailing 12-Months
Asset Growth
3.85%
Trailing 12-Months
Company Description
Pediatrix Medical Group, Inc.
Pediatrix Medical Group, Inc. delivers specialized medical services for newborns, expectant mothers, and pediatric patients across the United States and Puerto Rico. The company offers crucial neonatal care to critically ill or prematurely born infants within hospital units, staffed by expert neonatal subspecialists and advanced practice clinicians. For pregnant individuals and their developing babies, Pediatrix provides comprehensive maternal-fetal medicine services in both clinical and inpatient settings, involving specialists such as maternal-fetal medicine physicians, obstetricians, and genetic counselors. Furthermore, the group delivers pediatric cardiology services, addressing both congenital and acquired heart conditions in patients ranging from the fetal stage through adulthood, under the care of dedicated pediatric cardiologists. Beyond these core areas, Pediatrix extends its expertise to various other pediatric subspecialties, including those requiring intensivists, surgeons, and ophthalmologists, and supplies vital support to hospital departments like emergency rooms and labor and delivery units. Established in 1979 in Sunrise, Florida, and formerly known as MEDNAX, Inc. until its renaming in July 2022, the company managed a network of approximately 2,700 physicians as of February 2022.
MD Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presented a majority of positive operational and financial signals: strong Q1 adjusted EBITDA ($58M), above-expectation pricing growth (4%), improved collections (DSO down >5 days YoY), a solid cash balance, modest leverage (~1.3x), successful share repurchase, and strategic senior hires and partner-program rollout. Offsetting items include modest volume declines (NICU days down ~1%), rising clinical salary costs (+$9M S,W,B), higher Q1 cash usage ($130M vs $116M), and uncertainty around the sustainability of RCM-driven pricing and potential effects from tax subsidy lapses. Overall, positives materially outweigh the negatives, though management flagged areas to monitor (pricing tailwind fade, hospital pressures, and executive transition).View all MD earnings summariesMD Stock 12 Month Forecast
Average Price Target
$24.20
▲(4.90% Upside)
Technical Analysis
Healthcare Services
―
National Healthcare
―
Select Medical
―
Astrana Health
―
Aveanna Healthcare Holdings
―
Ownership Overview
1.54% Insiders
36.83% Mutual Funds
17.49% Other Institutional Investors
12.77% Public Companies and
Individual Investors